Clinical Trial Update: TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 trial of TPF induction chemotherapy for oropharyngeal and oral cavity cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer
• Squamous Cell Carcinoma of the Oral Cavity

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Orlando Guntinas-Lichius, Prof. Dr. med. | Conditions: Oropharynx Cancer, Squamous Cell Carcinoma of the Oral Cavity | Phase 1, Phase 2 | Status: COMPLETED